DMAC – diamedica therapeutics inc. (US:NASDAQ)
Stock Stats
News
Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight [Yahoo! Finance]
DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DiaMedica Therapeutics (NASDAQ:DMAC) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
Form SCHEDULE 13G/A DiaMedica Therapeutics Filed by: COOPERMAN LEON G
Form SCHEDULE 13G/A DiaMedica Therapeutics Filed by: DIALECTIC CAPITAL MANAGEMENT, LP
Form SCHEDULE 13G/A DiaMedica Therapeutics Filed by: TRILL AB
Form 4 DiaMedica Therapeutics For: Jan 02 Filed by: Parsons James T.
Form 4 DiaMedica Therapeutics For: Jan 02 Filed by: Giuffre Randall Michael
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.